drug-information.ru

Lucentis, |ranibizumab ophthalmic Ranibizumab

Drugs search, click the first letter of a drug name:

| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 2 | 3 | 4 | 5 | 6 | 8 | 9 Home

ranibizumab

Generic Name: ranibizumab (ophthalmic) (ra NIB i ZUE mab)
Brand Names: Lucentis

What is ranibizumab?

Ranibizumab is made from a human antibody fragment. It works by keeping new blood vessels from forming under the retina (a sensory membrane that lines the inside of the eye). In people with a certain type of eye disease, new blood vessels grow under the retina where they leak blood and fluid. This is known as the "wet form" of macular degeneration.

Ranibizumab is used to treat the wet form of age-related macular degeneration.

Ranibizumab may also be used for purposes other than those listed in this medication guide.

What is the most important information I should know about ranibizumab?

Do not receive this medication if you are allergic to ranibizumab, or if you have an infection in or around your eye. Before you receive this medication, tell your doctor if you have glaucoma.

Ranibizumab is given as an injection into your eye. Your doctor will use a medicine to numb your eye before giving you the injection. You will receive this injection in your doctor"s office or other clinic setting.

Ranibizumab is usually given once a month. After you have received the first 4 injections, your doctor may change your injection schedule to once every 3 months. Follow your doctor"s instructions.

Call your doctor at once if you have any of these serious side effects: vision changes, eye pain or redness, discharge or bleeding from your eye, increased eye sensitivity to light, swelling around the eye, or seeing flashes of light.

Call your doctor for instructions if you miss an appointment to receive your ranibizumab injection.

What should I discuss with my health care provider before receiving ranibizumab?

Do not receive this medication if you are allergic to ranibizumab, or if you have an infection in or around your eye.

Before you receive this medication, tell your doctor if you have glaucoma, or a history of blood clots or stroke.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether ranibizumab passes into breast milk or if it could harm a nursing baby. Do not receive this medication without telling your doctor if you are breast-feeding a baby.

How is ranibizumab used?

Ranibizumab is usually given once a month. After you have received the first 4 injections, your doctor may change your injection schedule to once every 3 months. Follow your doctor"s instructions.

For at least 30 minutes after your injection, your eyes will be checked periodically to make sure the injection has not caused any side effects.

To be sure this medication is helping your condition and not causing harmful effects, your eyes will also need to be checked on a regular basis. Do not miss any scheduled visits to your doctor.

What happens if I miss a dose?

Call your doctor for instructions if you miss an appointment to receive your ranibizumab injection.

What happens if I overdose?

Seek emergency medical attention if you think you have received too much of this medicine. Symptoms of a ranizumab overdose may include eye pain or vision changes.

What should I avoid while receiving ranibizumab?

There are no restrictions on food, beverages, or activity while receiving ranibizumab unless your doctor has told you otherwise.

Ranibizumab side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have any of these serious side effects:

vision changes;
eye pain, redness, or irritation;
discharge or bleeding from the eye;
increased eye sensitivity to light;
swelling around your eye;
seeing "stars" or flashes of light, especially in your peripheral (side) vision;
pain or burning when you urinate.
sudden numbness or weakness, especially on one side of the body; or
sudden headache, confusion, problems with vision, speech, or balance.

Other less serious side effects are more likely to occur, such as:

itchy or watery eyes;
dry eyes;
blurred vision;
runny or stuffy nose, cough, sore throat; or
joint or muscle pain.

Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.

What other drugs will affect ranibizumab?

There may be other drugs that can affect ranibizumab. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Where can I get more information?

Your pharmacist has information about ranibizumab written for health professionals that you may read.

What does my medication look like?

Ranibizumab is available with a prescription under the brand name Lucentis. Other brand or generic forms may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ("Multum") is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum"s drug information does not endorse drugs, diagnose patients or recommend therapy. Multum"s drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2006 Cerner Multum, Inc. Version: 1.03. Revision Date: 04/25/2007 11:40:45 AM.

Where can I get more information about ranibizumab ophthalmic Ranibizumab ? We recommend to use www.Drugs.com

Typical mistypes for ranibizumab ophthalmic Ranibizumab
eanibizumab ophthalmic ranibizumab, danibizumab ophthalmic ranibizumab, fanibizumab ophthalmic ranibizumab, tanibizumab ophthalmic ranibizumab, 5anibizumab ophthalmic ranibizumab, 4anibizumab ophthalmic ranibizumab, rznibizumab ophthalmic ranibizumab, rsnibizumab ophthalmic ranibizumab, rwnibizumab ophthalmic ranibizumab, rqnibizumab ophthalmic ranibizumab, rabibizumab ophthalmic ranibizumab, ramibizumab ophthalmic ranibizumab, rajibizumab ophthalmic ranibizumab, rahibizumab ophthalmic ranibizumab, ranubizumab ophthalmic ranibizumab, ranjbizumab ophthalmic ranibizumab, rankbizumab ophthalmic ranibizumab, ranobizumab ophthalmic ranibizumab, ran9bizumab ophthalmic ranibizumab, ran8bizumab ophthalmic ranibizumab, ranivizumab ophthalmic ranibizumab, raninizumab ophthalmic ranibizumab, ranihizumab ophthalmic ranibizumab, ranigizumab ophthalmic ranibizumab, ranibuzumab ophthalmic ranibizumab, ranibjzumab ophthalmic ranibizumab, ranibkzumab ophthalmic ranibizumab, ranibozumab ophthalmic ranibizumab, ranib9zumab ophthalmic ranibizumab, ranib8zumab ophthalmic ranibizumab, ranibixumab ophthalmic ranibizumab, ranibisumab ophthalmic ranibizumab, ranibiaumab ophthalmic ranibizumab, ranibizymab ophthalmic ranibizumab, ranibizhmab ophthalmic ranibizumab, ranibizjmab ophthalmic ranibizumab, ranibizimab ophthalmic ranibizumab, ranibiz8mab ophthalmic ranibizumab, ranibiz7mab ophthalmic ranibizumab, ranibizunab ophthalmic ranibizumab, ranibizukab ophthalmic ranibizumab, ranibizujab ophthalmic ranibizumab, ranibizumzb ophthalmic ranibizumab, ranibizumsb ophthalmic ranibizumab, ranibizumwb ophthalmic ranibizumab, ranibizumqb ophthalmic ranibizumab, ranibizumav ophthalmic ranibizumab, ranibizuman ophthalmic ranibizumab, ranibizumah ophthalmic ranibizumab, ranibizumag ophthalmic ranibizumab, ranibizumab iphthalmic ranibizumab, ranibizumab kphthalmic ranibizumab, ranibizumab lphthalmic ranibizumab, ranibizumab pphthalmic ranibizumab, ranibizumab 0phthalmic ranibizumab, ranibizumab 9phthalmic ranibizumab, ranibizumab oohthalmic ranibizumab, ranibizumab olhthalmic ranibizumab, ranibizumab o-hthalmic ranibizumab, ranibizumab o0hthalmic ranibizumab, ranibizumab opgthalmic ranibizumab, ranibizumab opbthalmic ranibizumab, ranibizumab opnthalmic ranibizumab, ranibizumab opjthalmic ranibizumab, ranibizumab oputhalmic ranibizumab, ranibizumab opythalmic ranibizumab, ranibizumab ophrhalmic ranibizumab, ranibizumab ophfhalmic ranibizumab, ranibizumab ophghalmic ranibizumab, ranibizumab ophyhalmic ranibizumab, ranibizumab oph6halmic ranibizumab, ranibizumab oph5halmic ranibizumab, ranibizumab ophtgalmic ranibizumab, ranibizumab ophtbalmic ranibizumab, ranibizumab ophtnalmic ranibizumab, ranibizumab ophtjalmic ranibizumab, ranibizumab ophtualmic ranibizumab, ranibizumab ophtyalmic ranibizumab, ranibizumab ophthzlmic ranibizumab, ranibizumab ophthslmic ranibizumab, ranibizumab ophthwlmic ranibizumab, ranibizumab ophthqlmic ranibizumab, ranibizumab ophthakmic ranibizumab, ranibizumab ophthapmic ranibizumab, ranibizumab ophthaomic ranibizumab, ranibizumab ophthalnic ranibizumab, ranibizumab ophthalkic ranibizumab, ranibizumab ophthaljic ranibizumab, ranibizumab ophthalmuc ranibizumab, ranibizumab ophthalmjc ranibizumab, ranibizumab ophthalmkc ranibizumab, ranibizumab ophthalmoc ranibizumab, ranibizumab ophthalm9c ranibizumab, ranibizumab ophthalm8c ranibizumab, ranibizumab ophthalmix ranibizumab, ranibizumab ophthalmiv ranibizumab, ranibizumab ophthalmif ranibizumab, ranibizumab ophthalmid ranibizumab, ranibizumab ophthalmic eanibizumab, ranibizumab ophthalmic danibizumab, ranibizumab ophthalmic fanibizumab, ranibizumab ophthalmic tanibizumab, ranibizumab ophthalmic 5anibizumab, ranibizumab ophthalmic 4anibizumab, ranibizumab ophthalmic rznibizumab, ranibizumab ophthalmic rsnibizumab, ranibizumab ophthalmic rwnibizumab, ranibizumab ophthalmic rqnibizumab, ranibizumab ophthalmic rabibizumab, ranibizumab ophthalmic ramibizumab, ranibizumab ophthalmic rajibizumab, ranibizumab ophthalmic rahibizumab, ranibizumab ophthalmic ranubizumab, ranibizumab ophthalmic ranjbizumab, ranibizumab ophthalmic rankbizumab, ranibizumab ophthalmic ranobizumab, ranibizumab ophthalmic ran9bizumab, ranibizumab ophthalmic ran8bizumab, ranibizumab ophthalmic ranivizumab, ranibizumab ophthalmic raninizumab, ranibizumab ophthalmic ranihizumab, ranibizumab ophthalmic ranigizumab, ranibizumab ophthalmic ranibuzumab, ranibizumab ophthalmic ranibjzumab, ranibizumab ophthalmic ranibkzumab, ranibizumab ophthalmic ranibozumab, ranibizumab ophthalmic ranib9zumab, ranibizumab ophthalmic ranib8zumab, ranibizumab ophthalmic ranibixumab, ranibizumab ophthalmic ranibisumab, ranibizumab ophthalmic ranibiaumab, ranibizumab ophthalmic ranibizymab, ranibizumab ophthalmic ranibizhmab, ranibizumab ophthalmic ranibizjmab, ranibizumab ophthalmic ranibizimab, ranibizumab ophthalmic ranibiz8mab, ranibizumab ophthalmic ranibiz7mab, ranibizumab ophthalmic ranibizunab, ranibizumab ophthalmic ranibizukab, ranibizumab ophthalmic ranibizujab, ranibizumab ophthalmic ranibizumzb, ranibizumab ophthalmic ranibizumsb, ranibizumab ophthalmic ranibizumwb, ranibizumab ophthalmic ranibizumqb, ranibizumab ophthalmic ranibizumav, ranibizumab ophthalmic ranibizuman, ranibizumab ophthalmic ranibizumah, ranibizumab ophthalmic ranibizumag, anibizumab ophthalmic ranibizumab, rnibizumab ophthalmic ranibizumab, raibizumab ophthalmic ranibizumab, ranbizumab ophthalmic ranibizumab, raniizumab ophthalmic ranibizumab, ranibzumab ophthalmic ranibizumab, ranibiumab ophthalmic ranibizumab, ranibizmab ophthalmic ranibizumab, ranibizuab ophthalmic ranibizumab, ranibizumb ophthalmic ranibizumab, ranibizuma ophthalmic ranibizumab, ranibizumabophthalmic ranibizumab, ranibizumab phthalmic ranibizumab, ranibizumab ohthalmic ranibizumab, ranibizumab opthalmic ranibizumab, ranibizumab ophhalmic ranibizumab, ranibizumab ophtalmic ranibizumab, ranibizumab ophthlmic ranibizumab, ranibizumab ophthamic ranibizumab, ranibizumab ophthalic ranibizumab, ranibizumab ophthalmc ranibizumab, ranibizumab ophthalmi ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic anibizumab, ranibizumab ophthalmic rnibizumab, ranibizumab ophthalmic raibizumab, ranibizumab ophthalmic ranbizumab, ranibizumab ophthalmic raniizumab, ranibizumab ophthalmic ranibzumab, ranibizumab ophthalmic ranibiumab, ranibizumab ophthalmic ranibizmab, ranibizumab ophthalmic ranibizuab, ranibizumab ophthalmic ranibizumb, ranibizumab ophthalmic ranibizuma, arnibizumab ophthalmic ranibizumab, rnaibizumab ophthalmic ranibizumab, rainbizumab ophthalmic ranibizumab, ranbiizumab ophthalmic ranibizumab, raniibzumab ophthalmic ranibizumab, ranibziumab ophthalmic ranibizumab, ranibiuzmab ophthalmic ranibizumab, ranibizmuab ophthalmic ranibizumab, ranibizuamb ophthalmic ranibizumab, ranibizumba ophthalmic ranibizumab, ranibizuma bophthalmic ranibizumab, ranibizumabo phthalmic ranibizumab, ranibizumab pohthalmic ranibizumab, ranibizumab ohpthalmic ranibizumab, ranibizumab opthhalmic ranibizumab, ranibizumab ophhtalmic ranibizumab, ranibizumab ophtahlmic ranibizumab, ranibizumab ophthlamic ranibizumab, ranibizumab ophthamlic ranibizumab, ranibizumab ophthalimc ranibizumab, ranibizumab ophthalmci ranibizumab, ranibizumab ophthalmi c ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic r anibizumab, ranibizumab ophthalmic arnibizumab, ranibizumab ophthalmic rnaibizumab, ranibizumab ophthalmic rainbizumab, ranibizumab ophthalmic ranbiizumab, ranibizumab ophthalmic raniibzumab, ranibizumab ophthalmic ranibziumab, ranibizumab ophthalmic ranibiuzmab, ranibizumab ophthalmic ranibizmuab, ranibizumab ophthalmic ranibizuamb, ranibizumab ophthalmic ranibizumba, rranibizumab ophthalmic ranibizumab, raanibizumab ophthalmic ranibizumab, rannibizumab ophthalmic ranibizumab, raniibizumab ophthalmic ranibizumab, ranibbizumab ophthalmic ranibizumab, ranibiizumab ophthalmic ranibizumab, ranibizzumab ophthalmic ranibizumab, ranibizuumab ophthalmic ranibizumab, ranibizummab ophthalmic ranibizumab, ranibizumaab ophthalmic ranibizumab, ranibizumabb ophthalmic ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab oophthalmic ranibizumab, ranibizumab opphthalmic ranibizumab, ranibizumab ophhthalmic ranibizumab, ranibizumab ophtthalmic ranibizumab, ranibizumab ophthhalmic ranibizumab, ranibizumab ophthaalmic ranibizumab, ranibizumab ophthallmic ranibizumab, ranibizumab ophthalmmic ranibizumab, ranibizumab ophthalmiic ranibizumab, ranibizumab ophthalmicc ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic ranibizumab, ranibizumab ophthalmic rranibizumab, ranibizumab ophthalmic raanibizumab, ranibizumab ophthalmic rannibizumab, ranibizumab ophthalmic raniibizumab, ranibizumab ophthalmic ranibbizumab, ranibizumab ophthalmic ranibiizumab, ranibizumab ophthalmic ranibizzumab, ranibizumab ophthalmic ranibizuumab, ranibizumab ophthalmic ranibizummab, ranibizumab ophthalmic ranibizumaab, ranibizumab ophthalmic ranibizumabb, etc.